Yair Herishanu
Tel Aviv University(IL)Tel Aviv Sourasky Medical Center(IL)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, CAR-T cell therapy research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia(2021)658 cited
- → Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial(2020)592 cited
- → COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus(2020)274 cited
- → Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia(2022)194 cited
- → Biology of Chronic Lymphocytic Leukemia in Different Microenvironments(2013)99 cited
- → Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study(2019)79 cited